0001192482-20-000348.txt : 20200515
0001192482-20-000348.hdr.sgml : 20200515
20200515161708
ACCESSION NUMBER: 0001192482-20-000348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200513
FILED AS OF DATE: 20200515
DATE AS OF CHANGE: 20200515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heffernan Michael Thomas
CENTRAL INDEX KEY: 0001448914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 20885481
MAIL ADDRESS:
STREET 1: C/O CORNERSTONE THERAPEUTICS INC.
STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-05-13
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001448914
Heffernan Michael Thomas
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
1
0
0
0
Common Stock
2020-05-13
4
S
0
1380
20.92
D
99670
D
Common Stock
2020-05-13
4
S
0
11969
21.21
D
87701
D
Common Stock
2020-05-13
4
S
0
5905
22.64
D
81796
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2019.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.87 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.01 to $22.00, inclusive.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.02 to $22.98, inclusive.
/s/ Paul Brannelly as Attorney-In-Fact For Michael T. Heffernan
2020-05-15